Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (731-740 of 738) with videos related to

Pageof 74
Sort By:
You have reached the last page of results.This site can display upto 738 results.
Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.
European Heart Journal|September 4, 2012
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practiceFaiez Zannad, Wendy Gattis Stough, Patrick Rossignol, et al.
Journal of the American College of Cardiology|September 12, 2013
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertensionMarkus P Schlaich, Roland E Schmieder, George Bakris, et al.
The New England Journal of Medicine|September 8, 2010
Intensive blood-pressure control in hypertensive chronic kidney diseaseLawrence J Appel, Jackson T Wright, Tom Greene, et al.
Journal of Diabetes and Its Complications|December 19, 2021
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John E Anderson, George L Bakris, et al.
JAMA|June 21, 2001
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trialL Y Agodoa, L Appel, G L Bakris, et al.
BMJ Open|December 22, 2018
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocolGianfranco Parati, Enrico Agabiti-Rosei, George L Bakris, et al.
Metabolism: Clinical and Experimental|June 9, 2024
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John E Anderson, George L Bakris, et al.
Pageof 74

Showing results (731-740 of 738) with videos related to

Sort By:
Pageof 74
You have reached the last page of results.This site can display upto 738 results.
Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.
European Heart Journal|September 4, 2012
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practiceFaiez Zannad, Wendy Gattis Stough, Patrick Rossignol, et al.
Journal of the American College of Cardiology|September 12, 2013
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertensionMarkus P Schlaich, Roland E Schmieder, George Bakris, et al.
The New England Journal of Medicine|September 8, 2010
Intensive blood-pressure control in hypertensive chronic kidney diseaseLawrence J Appel, Jackson T Wright, Tom Greene, et al.
Journal of Diabetes and Its Complications|December 19, 2021
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John E Anderson, George L Bakris, et al.
JAMA|June 21, 2001
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trialL Y Agodoa, L Appel, G L Bakris, et al.
BMJ Open|December 22, 2018
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocolGianfranco Parati, Enrico Agabiti-Rosei, George L Bakris, et al.
Metabolism: Clinical and Experimental|June 9, 2024
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John E Anderson, George L Bakris, et al.
Pageof 74